{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T02:16:15Z","timestamp":1770171375301,"version":"3.49.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178585","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:09:05Z","timestamp":1769040545000},"page":"178585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Triple drug co-delivery within nanosystems for synergistic anti-infective, anti-inflammatory, antinociceptive and neuroregenerative therapeutic effects: a focus on pharmacological and nanotechnological aspects"],"prefix":"10.1016","volume":"1015","author":[{"given":"Maria Sofia","family":"Anast\u00e1cio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cl\u00e1udia","family":"Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-4894","authenticated-orcid":false,"given":"Patr\u00edcia C.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178585_bib1","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2026.178585_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics17010036","article-title":"Liposomal formulations: a recent update","volume":"17","author":"Agrawal","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1381612826666191226100241","article-title":"Nanoemulgel: a promising phase in drug delivery","volume":"26","author":"Aithal","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.178585_bib4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jps.10154","article-title":"Excipient\u2013drug interactions in parenteral formulations","volume":"91","author":"Akers","year":"2002","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/pharmaceutics13071030","article-title":"Water-in-Oil nano-emulsions prepared by spontaneous emulsification: new insights on the formulation process","volume":"13","author":"Akram","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib6","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ndt\/gfae212","article-title":"Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease","volume":"40","author":"Alicic","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2026.178585_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms18050905","article-title":"Matrix metalloproteinase gene activation resulting from disordred epigenetic mechanisms in rheumatoid arthritis","volume":"18","author":"Araki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","article-title":"Psoriasis","volume":"11","author":"Armstrong","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.178585_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ddr.21768","article-title":"Design of multicomponent indomethacin\u2010paracetamol and famotidine loaded nanoparticles for sustained and effective anti\u2010inflammatory therapy","volume":"82","author":"Assali","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgh3.12843","article-title":"Management of Helicobacter pylori infection","volume":"7","author":"Aumpan","year":"2023","journal-title":"JGH Open"},{"key":"10.1016\/j.ejphar.2026.178585_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3390\/antibiotics13050396","article-title":"Exploring the molecular mechanisms of macrolide resistance in laboratory mutant Helicobacter pylori","volume":"13","author":"Aya\u015f","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejphar.2026.178585_bib12","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejphar.2026.178585_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40256-016-0175-2","article-title":"Triple combination therapy for global cardiovascular risk: Atorvastatin, perindopril, and amlodipine","volume":"16","author":"Bertrand","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ejphar.2026.178585_bib14","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/pharmaceutics15071977","article-title":"Recent advances in polycaprolactones for anticancer drug delivery","volume":"15","author":"Bhadran","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/acsptsci.2c00033","article-title":"Craft of Co-encapsulation in nanomedicine: a struggle to achieve synergy through reciprocity","volume":"5","author":"Bhattacharjee","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178585_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2015.05.020","article-title":"Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy","volume":"761","author":"Calzetta","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1124\/pharmrev.124.000951","article-title":"Drug-drug interactions and synergy: from pharmacological models to clinical application","volume":"76","author":"Calzetta","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.178585_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/13596535231201162","article-title":"HIV drug resistance in the era of contemporary antiretroviral therapy: a clinical perspective","volume":"28","author":"Carr","year":"2023","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016016167","article-title":"Niosomes as nano-delivery systems in the pharmaceutical field","volume":"33","author":"Cerqueira-Coutinho","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejphar.2026.178585_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib22","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejphar.2026.178585_bib23","article-title":"Nanoparticle drug delivery systems for synergistic delivery of tumor therapy","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12981-025-00745-5","article-title":"Global, regional and national burden of HIV\/AIDS among individuals aged 15-79 from 1990 to 2021","volume":"22","author":"Chen","year":"2025","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib25","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.3390\/ijms23147597","article-title":"Toxicologic concerns with current medical nanoparticles","volume":"23","author":"Cheng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib27","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178585_bib28","author":"Clogston"},{"key":"10.1016\/j.ejphar.2026.178585_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/pharmaceutics16091200","article-title":"Improving skin cancer treatment by dual drug Co-Encapsulation into liposomal systems - an integrated approach towards anticancer synergism and targeted delivery","volume":"16","author":"Corte-Real","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.178585_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.178585_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.178585_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112570","article-title":"TRIAL-based combination therapies in cancers","volume":"138","author":"Deng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2334-9-198","article-title":"Combination antiretroviral drugs in PLGA nanoparticle for HIV-1","volume":"9","author":"Destache","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejphar.2026.178585_bib36","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178585_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0705469","article-title":"Novel data point to a broader mechanism of action of oxidized ATP: the P2X 7 receptor is not the only target","volume":"140","author":"Di Virgilio","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108192","article-title":"Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy","volume":"34","author":"Dong","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejphar.2026.178585_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/pharmaceutics15010164","article-title":"Nanoemulgel: a novel nano carrier as a tool for topical drug delivery","volume":"15","author":"Donthi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib40","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105491","article-title":"Glucocorticoids in rheumatoid arthritis: balancing benefits and harm by leveraging the therapeutic window of opportunity","volume":"90","author":"Doumen","year":"2023","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.ejphar.2026.178585_bib42","article-title":"Topical delivery of nanoemulsions for skin cancer treatment","volume":"35","author":"Duarte","year":"2023","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ejphar.2026.178585_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2024.101875","article-title":"Liposomes: bridging the gap from lab to pharmaceuticals","volume":"75","author":"Eugster","year":"2025","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib44","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/pharmaceutics16091172","article-title":"Exploring protein-based carriers in drug delivery: a review","volume":"16","author":"Ferraro","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100327","article-title":"Harnessing combination therapy: current treatments, recent advancements, and future directions in Alzheimer's disease","volume":"12","author":"Fillit","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.ejphar.2026.178585_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.ejphar.2026.178585_bib47","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1016\/S2352-3018(22)00249-1","article-title":"Two-drug regimens for HIV treatment","volume":"9","author":"Gibas","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ejphar.2026.178585_bib48","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/molecules26061576","article-title":"Lipid formulations and bioconjugation strategies for indomethacin therapeutic advances","volume":"26","author":"Gliszczy\u0144ska","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178585_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124708","article-title":"Fabrication of a novel macrophage-targeted biomimetic delivery composite hydrogel with multiple-sensitive properties for tri-modal combination therapy of rheumatoid arthritis","volume":"665","author":"Gong","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2026.178585_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114505","article-title":"Dual-drug codelivery nanosystems: an emerging approach for overcoming cancer multidrug resistance","volume":"161","author":"Gong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178585_bib51","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2026.178585_bib52","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: formation, properties and applications","volume":"12","author":"Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejphar.2026.178585_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20406","article-title":"Treatment of H. pylori infection and gastric ulcer: need for novel pharmaceutical formulation","volume":"9","author":"Gupta","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2026.178585_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1535370218787770","article-title":"Localized and targeted delivery of NSAIDs for treatment of inflammation: a review","volume":"244","author":"Haley","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1461756","article-title":"Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective","volume":"15","author":"Han","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178585_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231220809","article-title":"Eradicate Helicobacter pylori first, or treat peptic ulcer disease?","volume":"11","author":"He","year":"2023","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib57","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamapsychiatry.2021.4313","article-title":"Combining antidepressants vs antidepressant monotherapy for treatment of patients with acute depression","volume":"79","author":"Henssler","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178585_bib58","article-title":"Development and evaluation of polyvinyl alcohol stabilized polylactide-co-caprolactone-based nanoparticles for brain delivery","volume":"61","author":"Higazy","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejphar.2026.178585_bib59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00535-009-0102-2","article-title":"Present status and strategy of NSAIDs-induced small bowel injury","volume":"44","author":"Higuchi","year":"2009","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178585_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/molecules29020540","article-title":"Bioactivities and mechanisms of action of sinomenine and its derivatives: a comprehensive review","volume":"29","author":"Hou","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178585_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004985","article-title":"CR3 and Dectin-1 collaborate in macrophage cytokine response through association on lipid rafts and activation of Syk-JNK-AP-1 pathway","volume":"11","author":"Huang","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejphar.2026.178585_bib62","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.3748\/wjg.v25.i34.5097","article-title":"Optimizing proton pump inhibitors in Helicobacter pylori treatment: old and new tricks to improve effectiveness","volume":"25","author":"Ierardi","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178585_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1755-5949.2009.00081.x","article-title":"Lomerizine, a Ca 2+ channel blocker, protects against neuronal degeneration within the visual center of the brain after retinal damage in mice","volume":"16","author":"Ito","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib64","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/pharmaceutics16101333","article-title":"Innovations in nanoemulsion technology: enhancing drug delivery for oral, parenteral, and ophthalmic applications","volume":"16","author":"Jacob","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9090325","article-title":"Targeted therapeutic nanoparticles: an immense promise to fight against cancer","volume":"2017","author":"Jahan","year":"2017","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.ejphar.2026.178585_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015010903","article-title":"Ligand-appended BBB-targeted nanocarriers (LABTNs)","volume":"32","author":"Jain","year":"2015","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejphar.2026.178585_bib67","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/138161206776055813","article-title":"Limitations of current antiretroviral agents and opportunities for development","volume":"12","author":"Jain","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.178585_bib68","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jmmm.2016.06.045","article-title":"The effect of poly vinyl alcohol (PVA) surfactant on phase formation and magnetic properties of hydrothermally synthesized CoFe2O4 nanoparticles","volume":"419","author":"Jalalian","year":"2016","journal-title":"J. Magn. Magn Mater."},{"key":"10.1016\/j.ejphar.2026.178585_bib69","article-title":"A systematic review: Sinomenine","volume":"10","author":"Jiang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2026.178585_bib70","article-title":"Polymeric nanoparticles for targeted treatment in oncology: current insights","volume":"1001","author":"Joshi","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.178585_bib71","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.178585_bib72","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.clgc.2023.12.018","article-title":"Real-world evidence of triplet therapy in metastatic hormone-sensitive prostate cancer: an Austrian multicenter study","volume":"22","author":"Kafka","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.ejphar.2026.178585_bib73","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jff.2017.07.061","article-title":"Immune effects of \u03b2-glucan are determined by combined effects on Dectin-1, TLR2, 4 and 5","volume":"37","author":"Kanjan","year":"2017","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.ejphar.2026.178585_bib74","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.2147\/DDDT.S520555","article-title":"Therapeutic potential of curcumin and novel formulations in psoriasis treatment: evidence and future prospects","volume":"19","author":"Kantasa","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib75","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14787210.2017.1410434","article-title":"Combination therapy for extensively-drug resistant gram-negative bacteria","volume":"15","author":"Karaiskos","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib76","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejmech.2017.09.056","article-title":"Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities","volume":"141","author":"Kassab","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178585_bib77","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","article-title":"Helicobacter pylori world gastroenterology organization global guideline","volume":"57","author":"Katelaris","year":"2023","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ejphar.2026.178585_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3109\/21556660.2014.895371","article-title":"Pharmacodynamic evaluation of intragastric pH and implications for famotidine dosing in the prophylaxis of non-steroidal anti-inflammatory drug induced gastropathy\u2014a proof of concept analysis","volume":"3","author":"Kent","year":"2014","journal-title":"J Drug Assess"},{"key":"10.1016\/j.ejphar.2026.178585_bib79","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2174\/1389450121999201125200558","article-title":"A review on rheumatoid arthritis interventions and current developments","volume":"22","author":"Khanna","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2026.178585_bib80","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s13346-020-00852-y","article-title":"Novel nanoemulsion gel containing triple natural bio-actives combination of curcumin, thymoquinone, and resveratrol improves psoriasis therapy: in vitro and in vivo studies","volume":"11","author":"Khatoon","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib81","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1111\/dom.15705","volume":"26","author":"Kim","year":"2024","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejphar.2026.178585_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126599","article-title":"Resveratrol ameliorates imiquimod-induced psoriasis-like skin inflammation in mice","volume":"10","author":"Kj\u00e6r","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178585_bib83","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/s41467-021-22557-7","article-title":"Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides","volume":"12","author":"Kocsm\u00e1r","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.178585_bib84","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1097\/QAD.0000000000001969","article-title":"Extended cell and plasma drug levels after one dose of a three-in-one nanosuspension containing lopinavir, efavirenz, and tenofovir in nonhuman primates","volume":"32","author":"Koehn","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2026.178585_bib85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijbiomac.2020.12.108","article-title":"Protein corona, understanding the nanoparticle\u2013protein interactions and future perspectives: a critical review","volume":"169","author":"Kopac","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2026.178585_bib86","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MNH.0000000000000929","article-title":"Combination therapy with kidney protective therapies: optimizing the benefits?","volume":"33","author":"Kotwal","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2026.178585_bib87","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/QAD.0000000000001405","article-title":"Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma","volume":"31","author":"Kraft","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2026.178585_bib88","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2018.02.003","article-title":"Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle formulation","volume":"275","author":"Kraft","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.178585_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13643-024-02695-x","article-title":"Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis","volume":"13","author":"Lai","year":"2024","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.178585_bib90","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111502","article-title":"Polydopamine-based nanomaterials and their potentials in advanced drug delivery and therapy","volume":"199","author":"Li","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejphar.2026.178585_bib92","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molimm.2021.03.015","article-title":"Thymoquinone, extract from Nigella sativa seeds, protects human skin keratinocytes against UVA-irradiated oxidative stress, inflammation and mitochondrial dysfunction","volume":"135","author":"Liang","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178585_bib93","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/tcr.202000170","article-title":"Polydopamine\u2010based nanoparticles for photothermal therapy\/chemotherapy and their synergistic therapy with autophagy inhibitor to promote antitumor treatment","volume":"21","author":"Lu","year":"2021","journal-title":"Chem. Rec."},{"key":"10.1016\/j.ejphar.2026.178585_bib94","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12951-025-03448-1","article-title":"Layered double hydroxides for regenerative nanomedicine and tissue engineering: recent advances and future perspectives","volume":"23","author":"Luo","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.178585_bib95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2019.11.037","article-title":"Dual and multi-targeted nanoparticles for site-specific brain drug delivery","volume":"317","author":"Luo","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.178585_bib96","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/polym15020355","article-title":"Temperature induced gelation and antimicrobial properties of pluronic F127 based systems","volume":"15","author":"Lupu","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejphar.2026.178585_bib97","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/gels11070544","article-title":"A comprehensive review of thermosensitive hydrogels: mechanism, optimization strategies, and applications","volume":"11","author":"Lv","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ejphar.2026.178585_bib98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.intimp.2015.06.023","article-title":"Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review","volume":"28","author":"Majdalawieh","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib99","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.ejphar.2026.178585_bib100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.178585_bib101","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/ijms19113408","article-title":"The effects of a combination of ion channel inhibitors in female rats following repeated mild traumatic brain injury","volume":"19","author":"Mao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib102","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/antiox12111954","article-title":"Resveratrol and its derivatives in inflammatory skin disorders - atopic dermatitis and psoriasis: a review","volume":"12","author":"Marko","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2026.178585_bib103","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3390\/v16091484","article-title":"New therapies and strategies to curb HIV infections with a focus on macrophages and reservoirs","volume":"16","author":"Marra","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2026.178585_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119289","article-title":"Protein-based nanoparticles for drug delivery purposes","volume":"581","author":"Mart\u00ednez-L\u00f3pez","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2026.178585_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2249834","article-title":"Psoriasis between autoimmunity and oxidative stress: changes induced by different therapeutic approaches","volume":"2022","author":"Medovic","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.178585_bib106","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with 2 antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 infection in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejphar.2026.178585_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113516","article-title":"Enhanced stability and photothermal efficiency of indocyanine green J-aggregates by nanoformulation with Calix[4]arene for photothermal therapy of cancers","volume":"230","author":"Millard","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejphar.2026.178585_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1416842","article-title":"Nano-based formulations of thymoquinone are new approaches for psoriasis treatment: a literature review","volume":"15","author":"Modarresi Chahardehi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178585_bib109","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.178585_bib110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10856-023-06748-w","article-title":"Targeted delivery of a short antimicrobial peptide (CM11) against Helicobacter pylori gastric infection using concanavalin A-coated chitosan nanoparticles","volume":"34","author":"Moosazadeh Moghaddam","year":"2023","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/hiv.12716","article-title":"Two\u2010drug vs. three\u2010drug combinations for HIV\u20101: do we have enough data to make the switch?","volume":"20","author":"Moreno","year":"2019","journal-title":"HIV Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001244","article-title":"Excitatory amino acid antagonists for acute stroke","author":"Muir","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.178585_bib113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1208\/s12249-024-02997-2","article-title":"Understanding microemulsions and nanoemulsions in (Trans)Dermal delivery","volume":"26","author":"Musakhanian","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejphar.2026.178585_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130931","article-title":"Pluronic stabilized conjugated polymer nanoparticles for NIR fluorescence imaging and dual phototherapy applications","volume":"1243","author":"Nagy-Simon","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejphar.2026.178585_bib115","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1039\/C9RA09523C","article-title":"Protein corona formation moderates the release kinetics of ion channel antagonists from transferrin-functionalized polymeric nanoparticles","volume":"10","author":"Naidu","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejphar.2026.178585_bib116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3164\/jcbn.2008041","article-title":"Prevention of indomethacin-induced gastric mucosal injury in helicobacter pylori-negative healthy volunteers: a comparison study rebamipide vs famotidine","volume":"43","author":"Naito","year":"2008","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ejphar.2026.178585_bib117","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","article-title":"Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives","volume":"14","author":"N\u00e9meth","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178585_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2014.00019","article-title":"Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing","volume":"1","author":"Nishizawa","year":"2014","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2026.178585_bib119","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cpt.1434","article-title":"Pharmacodynamic drug\u2013drug interactions","volume":"105","author":"Niu","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117909","article-title":"Enhanced therapeutic precision using dual drug-loaded nanomaterials for targeted cancer photodynamic therapy","volume":"184","author":"Obalola","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178585_bib121","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers16030546","article-title":"Cancer and HIV: the molecular mechanisms of the deadly duo","volume":"16","author":"Omar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.178585_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248866","article-title":"Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: systematic review and network meta-analysis","volume":"16","author":"Paglia","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178585_bib123","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine Scale-up technologies: feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejphar.2026.178585_bib124","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/nnm.16.42","article-title":"Twenty-five years of nano-bio-materials: have we revolutionized healthcare?","volume":"11","author":"Pandit","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejphar.2026.178585_bib125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1574884712666170509161252","article-title":"Safety and toxicological considerations of nanomedicines: the future directions","volume":"12","author":"Patel","year":"2018","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejphar.2026.178585_bib127","series-title":"Introduction to Basics of Pharmacology and Toxicology","first-page":"81","article-title":"Drug absorption and bioavailability","author":"Paul","year":"2019"},{"key":"10.1016\/j.ejphar.2026.178585_bib128","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1007\/s13346-025-01864-2","article-title":"Injectable nanocomposite hydrogels for targeted intervention in cancer, wound healing, and bone and myocardial tissue engineering","volume":"15","author":"Pereira","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib129","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1021\/acsnano.9b01087","article-title":"Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor","volume":"13","author":"Phua","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2026.178585_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2017.11.047","article-title":"Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies","volume":"270","author":"Pires","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2026.178585_bib131","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib132","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/10611860802295839","article-title":"Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori","volume":"16","author":"Ramteke","year":"2008","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejphar.2026.178585_bib133","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14656566.2020.1845314","article-title":"Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review","volume":"22","author":"Ritondo","year":"2021","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178585_bib134","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/life12122038","article-title":"Helicobacter pylori: a review of current treatment options in clinical practice","volume":"12","author":"Roberts","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2026.178585_bib135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2459\/JCM.0000000000001734","article-title":"Multidisciplinary approach and combination pharmacotherapy for the management of cardiometabolic patients","volume":"26","author":"Rosano","year":"2025","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib136","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.3390\/polym15224375","article-title":"Microfluidic-assisted formulation of \u03b5-Polycaprolactone nanoparticles and evaluation of their properties and in vitro cell uptake","volume":"15","author":"Rybak","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejphar.2026.178585_bib137","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/2589977511666191024173508","article-title":"Nanoemulsion as oral drug delivery - a review","volume":"12","author":"Sabjan","year":"2020","journal-title":"Curr Drug Res Rev"},{"key":"10.1016\/j.ejphar.2026.178585_bib138","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.07.034","article-title":"Three Ca2+ channel inhibitors in combination limit chronic secondary degeneration following neurotrauma","volume":"75","author":"Savigni","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.178585_bib139","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acsnano.0c09382","article-title":"Hybrid nanosystems for biomedical applications","volume":"15","author":"Seaberg","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2026.178585_bib140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113816128283466231219071151","article-title":"Nanocomposite hydrogels - a promising approach towards enhanced bioavailability and controlled drug delivery","volume":"30","author":"Shahid","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2026.178585_bib141","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1089\/aid.2012.0301","article-title":"Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment","volume":"29","author":"Shibata","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ejphar.2026.178585_bib142","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcis.2019.12.096","article-title":"Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development","volume":"565","author":"Shriky","year":"2020","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib143","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1038\/s41598-024-59234-w","article-title":"Probing the expression and adhesion of glycans involved in Helicobacter pylori infection","volume":"14","author":"Sijmons","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178585_bib144","doi-asserted-by":"crossref","first-page":"50953","DOI":"10.1021\/acsami.3c13395","article-title":"Metal\u2013organic framework-supported catalase delivery for enhanced photodynamic therapy via hypoxia mitigation","volume":"15","author":"Sim","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejphar.2026.178585_bib145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejphar.2026.178585_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","article-title":"Poly-\u03f5-caprolactone microspheres and nanospheres: an overview","volume":"278","author":"Sinha","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2026.178585_bib147","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.37080","article-title":"Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review","author":"Sohail","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.178585_bib148","article-title":"Nanotechnology's applications and potential in various fields","author":"Soni","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.178585_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/143524","article-title":"Glucan particles for macrophage targeted delivery of nanoparticles","volume":"2012","author":"Soto","year":"2012","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.ejphar.2026.178585_bib150","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/molecules28248038","article-title":"The bioavailability of drugs\u2014the current state of knowledge","volume":"28","author":"Stielow","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.178585_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117258","article-title":"Beta-d-glucan-based drug delivery system and its potential application in targeting tumor associated macrophages","volume":"253","author":"Su","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejphar.2026.178585_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2022.100134","article-title":"Nano-based drug delivery systems: conventional drug delivery routes, recent developments and future prospects","volume":"15","author":"Sultana","year":"2022","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.ejphar.2026.178585_bib153","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1 beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178585_bib154","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/metabo13080897","article-title":"Pharmacokinetic and pharmacodynamic drug\u2013drug interactions: research methods and applications","volume":"13","author":"Sun","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.ejphar.2026.178585_bib155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7861\/clinmed.2021-0039","article-title":"Non-steroidal anti-inflammatory drugs and the gastrointestinal tract","volume":"21","author":"Tai","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejphar.2026.178585_bib156","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s12872-024-04339-3","article-title":"The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials","volume":"24","author":"Tang","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ejphar.2026.178585_bib157","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2013.06.008","article-title":"New perspectives in nanomedicine","volume":"140","author":"Thorley","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178585_bib158","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000003344","article-title":"Updated data and methods for the 2023 UNAIDS HIV estimates","volume":"95","author":"van Schalkwyk","year":"2024","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.ejphar.2026.178585_bib159","first-page":"1","article-title":"Protein based nanostructures for drug delivery","volume":"2018","author":"Verma","year":"2018","journal-title":"J. Pharm. (Lahore)"},{"key":"10.1016\/j.ejphar.2026.178585_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-Cell depletion in HIV-1 and HIV-2 infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178585_bib161","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.intimp.2010.11.018","article-title":"Immunosuppressive and anti-inflammatory activities of sinomenine","volume":"11","author":"Wang","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib162","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2147\/JIR.S416417","article-title":"Resveratrol ameliorates imiquimod-induced psoriasis-like mouse model via reducing macrophage infiltration and inhibiting glycolysis","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2026.178585_bib163","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular mechanisms of psoriasis pathogenesis: a systemic review","volume":"16","author":"Wu","year":"2023","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2026.178585_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107049","article-title":"Enhancing the photothermal properties of indocyanine green in melanoma spheroids via encapsulation in Span 80-containing lipid nanocapsules","volume":"208","author":"Wu","year":"2025","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.178585_bib165","article-title":"Natural product-based nanomedicine: recent advances and issues","volume":"6055","author":"Xu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.178585_bib166","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/rheumatology\/keu254","article-title":"Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation","volume":"53","author":"Xue","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejphar.2026.178585_bib167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41540-020-0136-x","article-title":"Stratification and prediction of drug synergy based on target functional similarity","volume":"6","author":"Yang","year":"2020","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.ejphar.2026.178585_bib168","doi-asserted-by":"crossref","first-page":"8546","DOI":"10.1039\/D0NR00454E","article-title":"A novel indomethacin\/methotrexate\/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis","volume":"12","author":"Yin","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejphar.2026.178585_bib169","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/gels11070520","article-title":"Dual-drug delivery systems using hydrogel\u2013nanoparticle composites: recent advances and key applications","volume":"11","author":"Yoon","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ejphar.2026.178585_bib170","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/polym15071596","article-title":"Nanoparticles as drug delivery systems: a review of the implication of nanoparticles' physicochemical properties on responses in biological systems","volume":"15","author":"Yusuf","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejphar.2026.178585_bib171","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.41398","article-title":"Comparing triple combination drug therapy and traditional monotherapy for better survival in patients with high-risk hypertension: a systematic review","author":"Zaman","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.178585_bib172","article-title":"Updating understanding of real-world adverse events associated with omeprazole","volume":"20","author":"Zhang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178585_bib173","article-title":"Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178585_bib174","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jiph.2023.01.014","article-title":"The global, regional, and national burden of tuberculosis in 204 countries and territories, 1990\u20132019","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ejphar.2026.178585_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102559","article-title":"Advances in genetic\u2013immunological targeted therapies for psoriasis","volume":"94","author":"Zhen","year":"2025","journal-title":"Curr. Opin. Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:01:26Z","timestamp":1770123686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":175,"alternative-id":["S0014299926000671"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178585","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triple drug co-delivery within nanosystems for synergistic anti-infective, anti-inflammatory, antinociceptive and neuroregenerative therapeutic effects: a focus on pharmacological and nanotechnological aspects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178585"}}